Importance of Subgroups in Heart Failure Clinical Trials - Part 2

Listen now

Description

Host Dr. Christopher O'Connor invites Drs. Scott Solomon, William Abraham, JoAnn Lindenfeld, Brian Claggett, Mona Fiuzat, and Mitchell Psotka to continue discussion of the importance of subgroups in heart failure clinical trials. How can we analyze subgroups and determine the differences between subgroups and special populations?

More Episodes

See all »

The Role of AI in the Future of Clinical Trials ad Therapeutic Development

How can artififcial intelligence enhance and augment clinical trials? In what ways can it be used responsibly to increase trial efficiency? Host Chris O'Connor invites Martin Cowie, JoAnn Lindenfeld, Scott Solomon, Jon Cunningham, Mona Fiuzat, and Mitch Psotka to discuss the role of AI in...

Published 03/30/24

Cardio Pod: Heart of the Matter

Published 03/30/24

Importance of Subgroups in Heart Failure Clinical Trials - Part 1

Host Dr. Christopher O'Connor invites Drs. Javed Butler, Mariell Jessup, and Mitchell Psotka to discuss the importance of subgroups in heart failure clinical trials. How do we appropriately define subgroups? Which groups should be included as standard practice in HF trials?

Published 11/07/23